Skip to main content

Advertisement

SpringerLink
Log in

Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Psoriasis vulgaris (PV), a chronic inflammatory skin disease, is a condition of increased oxidative stress (OxS). However, interest related to oxidative and carbonyl stress damages to proteins, such as the formation of advanced glycation end products (AGEs) and their precursor molecule methylglyoxal (MG) has been modest. The objective of this study was to compare the systemic levels of OxS markers in patients with PV and healthy controls (Co) and to investigate their correlation with the serum level of MG. Total peroxide concentration (TPX) and total antioxidant capacity (TAC) were estimated by means of spectrophotometry. The TPX and TAC ratio was regarded as OxS index (OSI). MG level was determined using ELISA. Compared to Co, patients with PV had significantly increased blood levels of TPX (P < 0.0001), OSI (P < 0.0001), and MG (P = 0.01), and lower TAC levels (P < 0.0001). Increase in body mass index (BMI) appeared to contribute to this imbalance as TAC levels decreased with increasing BMI (r = −0.252, P < 0.01). Increased TPX concentration was associated with higher serum level of MG (r = 0.610, P = 0.004), the latter being positively correlated with psoriasis area and severity index (r = 0.577, P = 0.008). In performed multivariate regression analysis, TPX, TAC, and OSI were all significant predictors of MG level. Our study gave further proof of increased systemic psoriasis-related OxS. MG serum level, reflecting simultaneously OxS as well as carbonyl stress status, could be used as a marker of disease activity in clinical trials while looking for new systemic therapies for psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ahmed N, Thornalley PJ (2007) Advanced glycation end products: what is their relevance to diabetic complications. Diabetes Obes Metab 9:233–245

    Article  PubMed  CAS  Google Scholar 

  2. Amstrong AW, Voyles SV, Amstrong EJ, Fuller EN, Rutledge JC (2011) Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci 63:1–9

    Article  Google Scholar 

  3. Brauchli YB, Jick SS, Meier CR (2008) Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol 159:1331–1337

    Article  PubMed  CAS  Google Scholar 

  4. Busch M, Franke S, Rüster C, Wolf G (2010) Advanced glycation end-products and the kidney. Eur J Clin Invest 40:742–755

    Article  PubMed  CAS  Google Scholar 

  5. Coimbra S, Oliveira H, Reis F, Belo L, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A (2010) Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 24:1386–1394

    Article  PubMed  CAS  Google Scholar 

  6. Damasiewicz-Bodzek A, Wielkoszynski T (2012) Advanced protein glycation in psoriasis. J Eur Acad Dermatol Venereol 26:172–179

    Article  PubMed  CAS  Google Scholar 

  7. Deeva I, Mariani S, De Luca C, Pacifico V, Leoni L, Raskovic D, Kharaeva Z, Korkina L, Pastore S (2010) Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease. Cytokine 49:163–170

    Article  PubMed  CAS  Google Scholar 

  8. Emre S, Metin A, Demirseren DD, Akoglu G, Oztekin A, Neselioglu S, Erel O (2012) The association of oxidative stress and disease activity in seborrheic dermatitis. Arch Dermatol Res 304:683–687

    Article  PubMed  CAS  Google Scholar 

  9. Emre S, Metin A, Demirseren DD, Kilic S, Isikoglu S, Erel O (2012) The relationship between oxidative stress, smoking and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol 25(7):782–787. doi:10.1111/j.1468-3083.2012.04700.x

    Google Scholar 

  10. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285

    Article  PubMed  CAS  Google Scholar 

  11. Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS (2009) Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol 160:1–7

    Article  PubMed  CAS  Google Scholar 

  12. Gabr SA, Al-Ghadir AH (2012) Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Arch Dermatol Res 304:451–457

    Article  PubMed  CAS  Google Scholar 

  13. Gaens KHJ, Stehouwer CDA, Schalkwijk CG (2013) Advanced glycation end products and its receptor for advanced glycation end products in obesity. Curr Opin Lipidol 24:4–11

    Article  PubMed  CAS  Google Scholar 

  14. Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597–605

    Article  PubMed  CAS  Google Scholar 

  15. Horoz M, Bolukbas C, Bolubkas FF, Aslan M, Koylu AO, Selek S, Erel O (2006) Oxidative stress in hepatitis C infected end stage renal disease subjects. BMC Infect Dis 6:114

    Article  PubMed  Google Scholar 

  16. Karg E, Papp F, Tassi N, Janaky T, Wittmann G, Turi S (2009) Enhanced methylglyoxal formation in the erythrocytes of hemodialyzed patients. Metabolism 58:976–982

    Article  PubMed  CAS  Google Scholar 

  17. Kaur S, Zilmer K, Leping V, Zilmer M (2012) Comparative study of systemic inflammatory responses in psoriasis vulgaris and mild to moderate allergic contact dermatitis. Dermatology 225:54–61

    Article  PubMed  CAS  Google Scholar 

  18. Koyama H, Nishizawa Y (2010) AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD? Eur J Clin Invest 40:623–635

    Article  PubMed  CAS  Google Scholar 

  19. Langely RG, Ellis CN (2004) Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician’s global assessment. J Am Acad Dermatol 51:563–569

    Article  Google Scholar 

  20. Li K, Amstrong AW (2012) A review of health outcomes in patients with psoriasis. Dermatol Clin 30:61–72

    Article  PubMed  Google Scholar 

  21. Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D (2006) The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol 126:291–299

    Article  PubMed  CAS  Google Scholar 

  22. Mallbris L, Granath F, Hamsten A, Stahle M (2006) Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 54:614–621

    Article  PubMed  Google Scholar 

  23. Mallipattu SK, He JC, Uribarri J (2012) Role of advanced glycation end products and potential therapeutic interventions in dialysis patients. Semin Dial 25(5):529–538. doi:10.1111/j.1525-139X.2012.01081.x

    Article  PubMed  Google Scholar 

  24. Miranda HV, Outeiro TF (2010) The sour side of neurodegenerative disorders: the effects of protein glycation. J Pathol 221:13–25

    Article  CAS  Google Scholar 

  25. Mulder DJ, vanHaelst PL, Gross S, de Leeuw K, Bijzet J, Graaff R, Gans RO, Zijlstra F, Smit AJ (2008) Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 197:217–223

    Article  PubMed  CAS  Google Scholar 

  26. Nakajima H, Nakajima K, Tarutani M, Morishige R, Sano S (2011) Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch Dermatol Res 303:451–455

    Article  PubMed  CAS  Google Scholar 

  27. Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T (2008) Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Diabetes Metab Res Rev 24:109–114

    Article  PubMed  CAS  Google Scholar 

  28. Piperi C, Adamopoulos C, Dalagiorgou G, Diamanti-kandarakis E, Papavassiliou AG (2012) Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metab 97:2231–2242

    Article  PubMed  CAS  Google Scholar 

  29. Price CL, Knight SC (2009) Methylglyoxal: possible link between hyperglycaemia and immune suppression? Trends Endocrin Metab 20:312–317

    Article  CAS  Google Scholar 

  30. Rabbani N, Thornalley PJ (2012) Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids 42:1133–1142

    Article  PubMed  CAS  Google Scholar 

  31. Raukas M, Rebane R, Mahlapuu R, Jefremov V, Zilmer K, Karelson E, Bogdanovic N, Zilmer M (2012) Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer’s disease and Swedish Familial Alzheimer’s disease brain. Free Rad Res 46:1490–1495

    Article  CAS  Google Scholar 

  32. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figneiredo A, Quintanilha A, Teixeira F (2001) Dislipidemia and oxidative stress in mild and severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 303:33–39

    Article  PubMed  CAS  Google Scholar 

  33. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figneiredo A, Quintanilha A, Teixeira F (2004) Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 150:232–244

    Article  PubMed  CAS  Google Scholar 

  34. Stephens JW, Khanolkar MP, Bain SC (2009) The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202:321–329

    Article  PubMed  CAS  Google Scholar 

  35. Zhou Q, Mrowietz U, Rostami-Yazdi M (2009) Oxidative stress in the pathogenesis of psoriasis. Free Rad Biol Med 47:891–905

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper. The study was supported by the Estonian Science Foundation grants No. 7549, and by targeted financing from the Ministry of Education and Science of Estonia (SF0180105s08 and SF0180043S07).

Author information

Authors and Affiliations

  1. Clinic of Dermatology, University of Tartu, 31 Raja St, 50417, Tartu, Estonia

    Sirje Kaur

  2. Institute of Biochemistry, the Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia

    Kersti Zilmer & Mihkel Zilmer

  3. Institute of Computer Sciences, University of Tartu, Tartu, Estonia

    Vambola Leping

Authors
  1. Sirje Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kersti Zilmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vambola Leping
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mihkel Zilmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sirje Kaur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaur, S., Zilmer, K., Leping, V. et al. Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis. Arch Dermatol Res 305, 489–494 (2013). https://doi.org/10.1007/s00403-013-1362-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-013-1362-5

Keywords

Search

Navigation